OptimizeRx Corporation (OPRX)

OptimizeRx Corporation (OPRX $14.65)
- $14.65 Cap: $263M
- View OPRX Profile
- View Questions on OPRX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

OptimizeRx Corporation (OPRX $14.65)
- $14.65 Cap: $263M
- View OPRX Profile
- View Questions on OPRX

Q: This healthcare tech stock just reported earnings, and appears to have beat on all marks. Yet the stock has dropped significantly since reporting. Wondering if you could give me your analysis if this is a good opportunity to buy relative to other healthcare tech, given its valuation metrics, support and resistance, and current growth trajectory. Any other similar small cap names in healthcare like this intrigue you right now?

Read Answer Asked by Thomas on November 14, 2025